Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,429
Closed -$292K 1353
2023
Q1
$292K Sell
7,429
-303,416
-98% -$12.6M 0.01% 907
2022
Q4
$13.1M Buy
+310,845
New +$12M 0.48% 44
2022
Q2
Sell
-39,230
Closed -$1.88M 1889
2022
Q1
$1.88M Sell
39,230
-437,483
-92% -$21.7M 0.07% 269
2021
Q4
$24.2M Buy
+476,713
New +$21.2M 0.94% 18
2021
Q2
Sell
-45,974
Closed -$2.43M 1628
2021
Q1
$2.43M Buy
+45,974
New +$2.5M 0.08% 252

Other funds holding NUS

Ergoteles's NUS Position: Q2 2023 in Review

Ergoteles sold out of Nu Skin (NUS) in Q2 2023, closing a stake of 7,429 shares — an estimated $292K sold.

Ergoteles first reported a position in NUS in Q1 2021 and held it in 5 quarters. The position peaked at $24.2M in Q4 2021. 219 funds tracked by Wall St. Rank hold NUS as of Q2 2023.

  • Ergoteles reported no remaining Nu Skin position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 7,429 Nu Skin shares in Q2 2023, an estimated $292K.
  • Ergoteles first reported a position in Nu Skin in Q1 2021 and held it in 5 quarters.
  • Ergoteles's Nu Skin position peaked at $24.2M in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Nu Skin as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.